Most people in the United States are happy with their health insurance, but many still struggle with denied claims, delays and rising costs.

Scrolling is still a big part of daily life for American teenagers, despite mounting worries about screen time and mental health.

Severe obstruction prebronchodilator prevalence increased with age and was higher for middle-aged adults compared with children and young adults. Severe airflow obstruction was prevalent in children ...

A Prescription Drug User Fee Act target date of October 30, 2026 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the Biologics License Application ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

Topline data were announced from a phase 3 trial evaluating ceralasertib plus Imfinzi in patients with locally advanced or metastatic NSCLC.

Black and Hispanic/Latino patients with food allergies are less apt to recognize anaphylaxis and have more limited EAI access than White patients.

Nearly 1 in 4 Americans believe the US health care system is in crisis, and high costs are the top reason why.